Lutera
Product Images NDC 54868-6210
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lutera (NDC 54868-6210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
E0e1b7e9-figure-01 (Levonorgestrel And Ethinyl Estradiol Tablets Lut 1)
Levonorgestre| Ethinyl Estradiol is a combination medication consisting of a synthetic progestin and estrogen used for birth control. It works by preventing ovulation, altering the cervical mucus and uterine lining, making it difficult for sperm to fertilize an egg and for a fertilized egg to implant in the uterus. It is available in various forms such as pills, patches, and rings.*
Fig 1 Tab 1 (Levonorgestrel And Ethinyl Estradiol Tablets Lut 2)
This is a pharmacokinetic study of Lutera, a medication containing levonorgestrel and ethinyl estradiol. The study involved 22 subjects and their median serum concentration levels were recorded over a 21-day dosing period. The results are presented in Figure 1 and Table 1, which provide a summary of the pharmacokinetic parameters for levonorgestrel and ethinyl estradiol.*
Table 2 (Levonorgestrel And Ethinyl Estradiol Tablets Lut 3)
This document presents a table that shows the percentage of women who experienced unintended pregnancy during the first year of use of various contraceptive methods, taking into account both perfect use and typical use. The contraceptive methods included in the table are levonorgestrel implants, female sterilization, injectable progestogen, oral contraceptives (combined and progestin-only), progesterone, copper T 380A, condoms (male and female), cervical cap, diaphragm with spermicidal cream or jelly, spermicides alone, periodic abstinence, withdrawal, and no contraception. The percentages vary depending on the method used and how it is used. The table was adapted from the book Contraceptive Technology, 16th Revised Edition.*
Table 3 (Levonorgestrel And Ethinyl Estradiol Tablets Lut 4)
CIRCULATORY DISEASE MORTALITY RATES PER 100,000 WOMAN YEARS BY AGE, SMOKING STATUS AND ORAL-CONTRACEPTIVE USE. The text contains a table presenting mortality rates for circulatory disease based on age, smoking status, and whether or not women were using oral contraceptives. The table also includes data on ever-users/non-smokers, smokers, and controls. Adapted from a Lancet publication by P.M. Layde and V. Beral in 1981.*
Table 4 (Levonorgestrel And Ethinyl Estradiol Tablets Lut 5)
This text presents statistics on the annual number of deaths associated with different methods of fertility control per 100,000 nonsterile women, categorized by age group. The methods of control analyzed are oral contraceptives, IUD, condom, diaphragm/spermicide, and periodic abstinence. The outcomes analyzed are birth-related and method-related deaths. The data shows that oral contraceptives for smokers lead to higher death rates than oral contraceptives for non-smokers. The text provides a table with the figures for each age group and method of control.*
Face Card (Levonorgestrel And Ethinyl Estradiol Tablets Lut 6)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.